Skip to main content
Bio-Gate AG logo

Bio-Gate AG — Investor Relations & Filings

Ticker · BIG1 ISIN · DE000BGAG981 LEI · 391200G5LKTIOTZOXP90 F Manufacturing
Open in API
Filings indexed 242 across all filing types
Latest filing 2009-06-16 Regulatory Filings
Country DE Germany
Listing F BIG1

About Bio-Gate AG

https://www.bio-gate.de/en/

Bio-Gate AG is a provider of innovative technologies and customized solutions for health and hygiene, specializing in antimicrobial and antiviral strategies. The company enhances materials and products by incorporating its unique silver-based technologies, such as MicroSilver BG™. Key applications are concentrated in the medical technology sector, including the coating of medical implants and wound dressings to prevent infections. The company's technologies are also utilized in derma-cosmetics and veterinary care products. Furthermore, Bio-Gate provides solutions for industrial and consumer goods, imparting antimicrobial properties to items like paints, coatings, plastics, and textiles.

Recent filings

Filing Released Lang Actions
Bio-Gate AG: Bio-Gate: Neue Kooperation mit US-Unternehmen beschleunigt Zugang zu den weltweiten Top-10-Medizintechnik-Herstellern
Regulatory Filings Classification · 100% confidence The document is a news release dated June 16, 2009, announcing a new cooperation/partnership between Bio-Gate AG and a US-based contract manufacturer to market Bio-Gate's antimicrobial coating technology (HyProtectTM) in the US medical technology sector. It details strategic goals, licensing agreements, and expected revenue potential. This type of announcement, focusing on business development, strategic partnerships, and market access, does not fit neatly into the specific financial reporting categories (like 10-K, ER, IR) or specific corporate actions (like DIV, SHA, POS). It is a general corporate announcement regarding business strategy and market expansion. Given the options, the most appropriate general category for a significant, non-standard corporate update that isn't a formal financial report or management change is 'Regulatory Filings' (RNS) as a catch-all for important news releases that don't fit elsewhere, although 'LTR' (Legal Proceedings Report) or 'MANG' (Board/Management Information) are clearly incorrect. Since it is a news release about a strategic business development, and 'RNS' is defined as 'General regulatory announcements and fallback category for miscellaneous filings that do not neatly fit into other specific categories,' RNS is the best fit among the provided codes for this type of strategic business update.
2009-06-16 German
Bio-Gate AG: Bio-Gate Tochter BioEpiderm erschliet europaische Markte fur das Kosmetikgeschaft
M&A Activity Classification · 99% confidence The document is a news release dated June 9, 2009, originating from Bio-Gate AG, distributed via DGAP (a German news service). It announces a new exclusive distribution agreement signed by its subsidiary, BioEpiderm, with the trading company IMPAG for the cosmetics business in France and Poland. This is a corporate announcement regarding business development and strategy, not a formal regulatory filing like a 10-K, an earnings release (ER), or a dividend notice (DIV). It details operational news, making it a general corporate news item. Since there is no specific category for general business updates or contract announcements that aren't related to M&A (TAR) or financing (CAP), the most appropriate fallback category is Regulatory Filings (RNS), which serves as a general announcement category for non-standard disclosures.
2009-06-09 German
Bio-Gate AG:Bio-Gate will im ersten Halbjahr 2010 die Gewinnzone erreichen
Earnings Release Classification · 100% confidence The document is titled 'Bio-Gate AG:Bio-Gate will im ersten Halbjahr 2010 die Gewinnzone erreichen' and explicitly mentions 'Veröffentlichung einer Corporate News' and 'Geschäftsbericht 2008'. It summarizes key financial outlooks for 2009 and 2010, referencing the 'Geschäftsbericht 2008' (Annual Report/Financial Year Report). However, the structure strongly resembles a press release announcing results and future guidance, rather than the full, detailed Annual Report (10-K) or a comprehensive Interim Report (IR). The text focuses on key highlights, management commentary, and future expectations, which aligns best with an Earnings Release (ER) or a Management Discussion & Analysis (MDA) summary, but given the context of summarizing the *past year's* report ('Geschäftsbericht 2008') and providing forward guidance, it functions as the initial public announcement of the annual performance summary. Since it is a detailed summary of the past year's performance and future outlook, it is classified as an Earnings Release (ER), which typically precedes or accompanies the full 10-K filing, or as a Management Report (MDA) if it were more focused on commentary. Given the structure and the mention of the 'Geschäftsbericht 2008' results, ER is the most appropriate fit for this type of announcement summarizing the fiscal year's outcome and outlook. FY 2008
2009-05-05 German
Bio-Gate AG: Bio-Gate startet strategische Neuausrichtung
M&A Activity Classification · 99% confidence The document is a corporate news release dated April 20, 2009, announcing a 'strategic realignment' (strategische Neuausrichtung) for Bio-Gate AG, specifically the termination of an exclusive cooperation agreement with Ciba and plans for future sales expansion. It discusses changes in revenue recognition and future business strategy. This type of announcement, detailing significant operational or strategic decisions that impact the business outlook but are not a full financial report (10-K, IR) or a formal earnings release (ER), fits best under the general category of corporate news or regulatory filings. Since it details strategic corporate decisions and operational changes, it is most closely aligned with general corporate updates. Given the options, and noting it is a news release about strategic corporate decisions rather than a specific financial filing, it is classified as a Regulatory Filing (RNS) as a general catch-all for significant, non-standard announcements, although it shares characteristics with MDA (Management Discussion/Outlook). However, RNS is the designated fallback for general regulatory announcements not covered elsewhere. It is not a formal financial report, earnings release, or management report detailing past performance, but rather a forward-looking strategic announcement.
2009-04-20 German
Bio-Gate AG: Ciba verzichtet auf Call-Option fur wesentlichen Teil des Bio-Gate Geschaftes
M&A Activity Classification · 99% confidence The document is a news release dated April 8, 2009, announcing that Ciba has waived its call option on a significant part of Bio-Gate AG's business. It discusses the implications for Bio-Gate's future business prospects and provides preliminary 2008 financial figures (revenue and loss). This type of announcement, detailing a significant corporate event (a contract change/waiver impacting business structure) that is not a standard periodic financial report (like 10-K or IR), nor a management change (MANG), nor a dividend announcement (DIV), nor a pure financing event (CAP), fits best under the general category for significant corporate news that doesn't fit elsewhere, which is Regulatory Filings (RNS). It is a 'Corporate News' announcement transmitted by DGAP, which often serves as a catch-all for material non-standard disclosures.
2009-04-08 German
Bio-Gate AG:Bio-Gate AG erhalt weiteren Entwicklungsauftrag
Regulatory Filings Classification · 100% confidence The document is a short news release dated January 15, 2009, announcing that Bio-Gate AG has received a new development contract for its HyProtect® coating for wound dressings. It mentions revenue recognition in the past fiscal year (2008) and discusses future cooperation phases. The text is clearly a press release ('Veröffentlichung einer Corporate News') detailing a business development, not a comprehensive financial report (like 10-K or IR), an earnings release (ER) focusing on period results, or a formal regulatory filing like a Director's Dealing (DIRS) or Major Shareholding (MRQ). Since it is a general business update/news announcement that doesn't fit the specific categories like ER, CT, or CAP, it falls best under the general regulatory announcement category, which is RNS (Regulatory Filings) as the fallback for miscellaneous announcements, or potentially LTR if it were a legal matter, but here it is a contract win. Given the options, RNS serves as the best fit for a general corporate news release that isn't a specific financial report or management change.
2009-01-15 German

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.